01:53 PM EDT, 03/18/2025 (MT Newswires) -- Health care stocks were edging lower Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing 0.1%.

The iShares Biotechnology ETF (IBB) fell 1%.

Eli Lilly ( LLY ) is down around 1% in afternoon trading. Redburn Atlantic Tuesday adjusted Lilly's price target to $800 from $700, while keeping its neutral rating.

In corporate news, Can-Fite BioPharma ( CANF ) shares jumped 18% after it said Tuesday that the US Food and Drug Administration has approved the compassionate use treatment with anti-cancer drug Namodenoson for a pancreatic cancer patient in the US.